News

Filter
266 found

MMV submits statement to 73rd World Health Assembly

19 May 2020

In support of the COVID-19 response

31 Mar 2020

Malaria continues to strike pregnant women and children hardest and new tools are critical, according to WHO’s latest report

05 Dec 2019

MMV presents Lifetime Achievement Awards to three longstanding collaborators

25 Nov 2019

MMV and PATH strengthen ties with APLMA in the fight against relapsing malaria

22 Oct 2019

WHO issues information note about Pyramax® (artesunate-pyronaridine) for uncomplicated malaria

09 Oct 2019

MMV contributes to the fight against schistosomiasis

30 Sep 2019

Via Grand Challenges Africa, MMV supports eight African drug discovery scientists

23 Sep 2019

Two reports on malaria eradication underline need for new tools and interventions

09 Sep 2019

MMV awards its Project of the Year 2018 to University of Dundee researchers

10 Jul 2019

MMV launches new P. vivax malaria information hub

26 Jun 2019

Prof Jonathan Vennerstrom receives prestigious ACS Award for Creative Invention

24 Apr 2019

MMV participates in Swiss World Malaria Day event

24 Apr 2019

Professor Michael Ferguson receives Knighthood in New Year’s Honours List

14 Jan 2019

2018 - A triumph of partnerships

19 Dec 2018

Open source effort identifies hundreds of compounds that could protect vulnerable populations from malaria

07 Dec 2018

Access to Medicines Index highlights role of collaboration in stimulating R&D

21 Nov 2018

Fosun Pharma’s medicine to protect pregnant women from malaria first to be approved by WHO

19 Nov 2018

Ray Chambers appointed WHO Ambassador for Global Strategy

31 Oct 2018

Professor James McCarthy elected Fellow of Australian Academy of Health and Medical Sciences

31 Oct 2018

Single-dose tafenoquine for radical cure of P. vivax malaria submitted for regulatory approval in Brazil

21 Sep 2018

MMV Project of the Year 2017 awarded to Sanofi

10 Jul 2018

Strides Shasun’s rectal artesunate product receives WHO prequalification

21 Jun 2018

MMV deeply saddened by the loss of Prof. Ogobara Doumbo

11 Jun 2018

Australia renews commitment to MMV and R&D for malaria

08 Jun 2018

MMV partner Kelly Chibale in Fortune Greatest Leaders list 2018

30 Apr 2018

MMV’s contributions to malaria commended at MIM conference

27 Apr 2018

Major study confirms tolerability and high efficacy of 4 gold-standard malaria medicines, when used for repeated treatment over a 2 year period

29 Mar 2018

MMV welcomes Philip Welkhoff, new Malaria Program Director, BMGF

14 Feb 2018

MMV and DNDi deliver joint statement at WHO Executive Board

27 Jan 2018

MMV end-of-year review 2017

02 Jan 2018

WHO issues information note on correct use of rectal artesunate for severe malaria

18 Dec 2017

Unitaid awards MMV new supply side grant

08 Dec 2017

PLOS Medicine publishes New Malaria Eradication Road Map

01 Dec 2017

Two new MMV-supported research sites inaugurated in Ethiopia

30 Nov 2017

Two MMV partners receive international award

30 Nov 2017

Global malaria response “off track” in 2016

29 Nov 2017

USAID renews support to MMV with new grant

09 Nov 2017

100 million vials of injectable artesunate distributed since 2010

06 Nov 2017

MMV backs training course for study coordinators

01 Nov 2017

MMV and Transaid partner to tackle severe malaria in Zambia

31 Oct 2017

MMV hosts international drug discovery meeting in Geneva

26 Oct 2017

Three vivax research teams awarded MMV Project of the Year 2016

10 Oct 2017

MMV discovery partners receive ASBMB awards

09 Oct 2017

Everything you always wanted to know about malaria and more

03 Aug 2017

Dr Tedros Adhanom Ghebreyesus elected as the new Director-General of WHO

24 May 2017

MMV and partners launch “call to action” to G20 health ministers

22 May 2017

MMV launches new Severe Malaria Observatory

18 May 2017

MMV and Aga Khan Foundation Canada come together to tackle malaria in Mali

01 May 2017

New publication highlights efficacy of MMV048 against resistant strains of malaria

27 Apr 2017

New antimalarial compound treats and protects in a single dose

29 Mar 2017

MMV 4th in top 10 rare infectious disease drug developers

28 Mar 2017

Awa Marie Coll-Seck receives Best Minister Award

27 Feb 2017

MMV shines a light on malaria in Times Square

22 Feb 2017

RBM appoints new CEO

27 Jan 2017

MMV delivers statement at 140th session of the WHO Executive Board

27 Jan 2017

MMV welcomes the launch of the End Malaria Council

25 Jan 2017

MMV brings new partner Janssen Pharmaceuticals on board

19 Jan 2017

MMV end-of-year review 2016

22 Dec 2016

Swiss Malaria Group invites you to enter photo and video competition

17 Dec 2016

Pages